1998: FDA approves LymeRIX with numerous provisos.
LYMErix is declared 76% effective (says Medline). Lyme disease was first called “Lyme Borreliosis” before tick borne disease began to be commercialized after the Bayh-Dole Act came into being, and was only called “Lyme disease” after the Dearborn Conference in 1994.
​
LYMErix was approved for use in ages 15-70 and recommended in endemic areas. At one point they tried to get it approved for use in children; fortunately that never happened.
​
The provisos (contraindications) included: Pregnant or breastfeeding mothers, children younger than 15 and adults over 70.
​
You want to read the entire 1998 FDA meeting transcript. Sikand claims Lyme is hard to diagnose and treat. Schoen says Lyme is underreported by 10-12 times, and Luft is going at these bastards over their disease definitions the entire time, as well as, says the vaccine injuries look exactly like the "protean" or multi-system disease definition and not the "bad knee only" definition.
